Global Bio Similars Competitive Landscape Professional Research Report 2025
Research SummaryBio similars, also known as biosimilars or follow-on biologics, are pharmaceutical products that are highly similar to an already approved reference biological product (also known as the originator or reference product). These bio similars are developed to be highly similar in terms of quality, efficacy, and safety to the reference product. However, unlike generic versions of small-molecule drugs, which are identical copies of their reference products, bio similars are not exact replicas due to the complexity of biological molecules. Bio similars undergo a rigorous process of development and testing to demonstrate similarity to the reference product, ensuring that they are effective and safe for use. They are often used as more affordable alternatives to the reference product, providing increased access to important treatments and promoting competition in the biopharmaceutical market.
According to DIResearch's in-depth investigation and research, the global Bio Similars market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Bio Similars include Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy's Laboratories, Stada Arzneimittel, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Bio Similars. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Bio Similars market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Bio Similars market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Bio Similars industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Bio Similars Include:
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Bio Similars Product Segment Include:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Bio Similars Product Application Include:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Chapter ScopeChapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Bio Similars Industry PESTEL Analysis
Chapter 3: Global Bio Similars Industry Porter’s Five Forces Analysis
Chapter 4: Global Bio Similars Major Regional Market Size and Forecast Analysis
Chapter 5: Global Bio Similars Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Bio Similars Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Bio Similars Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources